AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of ($1.50), $0.20 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $3.46 million versus the consensus estimate of $2.68 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.